The SEC announced charges against Decision Diagnostics (OTCMKTS:DECN) and its CEO, alleging false and misleading claims over a COVID-19 blood test. Westlake Village, Calif.-based Decision Diagnostics and its CEO Keith Berman are alleged to have made the claims in numerous press releases, saying that the company had developed a working, breakthrough technology for detecting COVID-19 […]
Decision Diagnostics
Decision Diagnostics sues J&J’s LifeScan over glucose test strip patents
Decision Diagnostics (OTC:DECN) said today its subsidiaries Decision IT and Pharma Tech Solutions filed a lawsuit against Johnson & Johnson (NYSE:JNJ) and its Lifescan divisions over patent infringement related to glucose testing strips, looking for compensation between $400 and $700 million. The Los Angeles-based company said the patent infringement case centers around 3 features and 2 […]
Decision Dx wins test strip patent challenge to J&J’s LifeScan
A federal appeals court yesterday upheld a U.S. Patent & Trademark Office decision that a blood glucose testing patent owned by JNJ subisidary LifeScan is invalid. The U.S. Court of Appeals for the Federal Circuit’s per curiam decision, issued without comment, was a win for Decision Diagnostics (OTC:DECN) subsidiary PharmaTech Solutions and its GenStrip 50 test strip. […]
Diabetes: J&J loses a round in glucose testing battle with Shasta
